FRONT-1 Phase 3 expected data readout accelerated from H2 2027 to H1 20274FRONT-2 Phase 3 trial initiated ahead of schedule Streamlined late-stage clinical and pre-commercial organization aligns with ...

Hyatt's asset-light strategy, strong international growth, and robust pipeline make it a smart investment. Click here to read ...

Genpact's AI-led transformation and GenpactNext strategy fuel double-digit EPS growth, expanded markets, and deeper client ...

Starburst unifies siloed data, simplifies AI workflows with Trino, and boosts LLM accuracy using RAG, governance, and open ...